Cargando…

Eudragit(®) Microparticles for the Release of Budesonide: A Comparative Study

This study compares the behaviour of budesonide-containing microparticles made of Eudragit(®)RS or Eudragit(®)RS/Eudragit(®)RL 70:30 (w/w) prepared either by solvent evaporation or spray-drying technique. The loading efficiency of budesonide within microparticles was about 72% for microparticles pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortesi, Rita, Ravani, Laura, Menegatti, Enea, Esposito, Elisabetta, Ronconi, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660867/ https://www.ncbi.nlm.nih.gov/pubmed/23716869 http://dx.doi.org/10.4103/0250-474X.108416

Ejemplares similares

Colloidal Dispersions for the Delivery of Acyclovir: A Comparative Study
por: Cortesi, Rita, et al.
Publicado: (2011)

Preparation and Evaluation of Mixture of Eudragit and Ethylcellulose Microparticles Loaded with Ranolazine for Controlled Release
por: Gowda, DV, et al.
Publicado: (2011)

Comparison of Simple Eudragit Microparticles Loaded with Prednisolone and Eudragit-Coated Chitosan-Succinyl-Prednisolone Conjugate Microparticles: Part II. In Vivo Evaluation of Efficacy, Toxicity, and Biodisposition Characteristics
por: Onishi, Hiraku, et al.
Publicado: (2015)

Eudragit(®) FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration
por: Tabare, Emilie, et al.
Publicado: (2023)

Preparation, Characterization and In Vitro Evaluation of Eudragit S100-Coated Bile Salt-Containing Liposomes for Oral Colonic Delivery of Budesonide
por: Alghurabi, Hamid, et al.
Publicado: (2022)

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
por: Roni, M. A., et al.
Publicado: (2009)

Effects of spray drying conditions on the physicochemical properties of the Tramadol-Hcl microparticles containing Eudragit(®) RS and RL
por: Patel, A. S., et al.
Publicado: (2012)

Nanoformulated Eudragit lopinavir and preliminary release of its loaded suppositories
por: Katata-Seru, Lebogang, et al.
Publicado: (2020)

The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices
por: Kaffash, Ehsan, et al.
Publicado: (2021)

Development of Lyophilised Eudragit(®) Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration
por: Lombardo, Rosamaria, et al.
Publicado: (2023)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

The Effect of Molecular Properties on Active Ingredient Release from Electrospun Eudragit Fibers
por: Burgess, Kieran, et al.
Publicado: (2018)

Lipid nanostructures for antioxidant delivery: a comparative preformulation study
por: Esposito, Elisabetta, et al.
Publicado: (2019)

Antifungal activity of osthol in vitro and enhancement in vivo through Eudragit S100 nanocarriers
por: Li, Lin-peng, et al.
Publicado: (2017)

In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets
por: Deb, Tamal Krishna, et al.
Publicado: (2015)

Eudragit Films as Carriers of Lipoic Acid for Transcorneal Permeability
por: Bierbrauer, Karina L., et al.
Publicado: (2023)

A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals
por: Song, Ivy H., et al.
Publicado: (2020)

Comparison of Aerosol Formulations of Formoterol Fumarate and Budesonide
por: Nirale, N. M., et al.
Publicado: (2011)

Continuous flow process for preparing budesonide
por: Phull, Manjinder Singh, et al.
Publicado: (2022)

Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres
por: Kenechukwu, Franklin C., et al.
Publicado: (2016)

Development and Characterization of Eudragit(®)-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
por: Vlachou, Marilena, et al.
Publicado: (2019)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Equilibrium and Release Properties of Aqueous Dispersions of Non-Steroidal Anti-Inflammatory Drugs Complexed with Polyelectrolyte Eudragit E 100
por: Quinteros, Daniela Alejandra, et al.
Publicado: (2012)

PAK4 suppresses TNF-induced release of endothelial microparticles in HUVECs cells
por: Zhang, Shouqin, et al.
Publicado: (2020)

Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation
por: Vultaggio-Poma, Valentina, et al.
Publicado: (2022)

Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery
por: Raval, Mihir K, et al.
Publicado: (2013)

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
por: Tang, Jingling, et al.
Publicado: (2011)

Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis
por: Reda, Rana Ihab, et al.
Publicado: (2017)

Endovascular Embolization of Brain Arteriovenous Malformations with Eudragit-E
por: TAMURA, Goichiro, et al.
Publicado: (2015)

Uptake of Eudragit Retard L (Eudragit(®) RL) Nanoparticles by Human THP-1 Cell Line and Its Effects on Hematology and Erythrocyte Damage in Rats
por: Abdel-Wahhab, Mosaad A., et al.
Publicado: (2014)

Acid sphingomyelinase activity triggers microparticle release from glial cells
por: Bianco, Fabio, et al.
Publicado: (2009)

Comparative Efficacy of Budesonide/Formoterol with Budesonide, Formoterol or Placebo for Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Tang, Bin, et al.
Publicado: (2019)

Ranitidine Hydrochloride-loaded Ethyl Cellulose and Eudragit RS 100 Buoyant Microspheres: Effect of pH Modifiers
por: Kotagale, N. R., et al.
Publicado: (2011)

Evaluation of the Antimicrobial Activity of a Formulation Containing Ascorbic Acid and Eudragit FS 30D Microparticles for the Controlled Release of a Curcumin–Boric Acid Solid Dispersion in Turkey Poults Infected with Salmonella enteritidis: A Therapeutic Model
por: Hernandez-Patlan, Daniel, et al.
Publicado: (2023)

Formulation and optimisation of lamivudine‐loaded Eudragit(®) S 100 polymer‐coated pectin microspheres for colon‐specific delivery
por: Vilas, Satheesh, et al.
Publicado: (2021)

Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit(®) S100 for pH Responsive Release of Tenofovir
por: Cazorla-Luna, Raúl, et al.
Publicado: (2020)

Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization
por: Ibrahim, Mohamed Abbas, et al.
Publicado: (2021)

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
por: Virchow, J. Christian, et al.
Publicado: (2016)

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
por: Jenkins, Christine R., et al.
Publicado: (2017)

Surface Deposition and Coalescence and Coacervation Phase Separation Methods: In Vitro Study and Compatibility Analysis of Eudragit RS30D, Eudragit RL30D, and Carbopol-PLA Loaded Metronidazole Microspheres
por: Dewan, Irin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_62n9oktao3kr6nq1te8tj984ja